Product NDC: | 67386-122 |
Proprietary Name: | NeoProfen |
Non Proprietary Name: | ibuprofen lysine |
Active Ingredient(s): | 10 mg/mL & nbsp; ibuprofen lysine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67386-122 |
Labeler Name: | Lundbeck Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021903 |
Marketing Category: | NDA |
Start Marketing Date: | 20060413 |
Package NDC: | 67386-122-52 |
Package Description: | 3 VIAL in 1 CARTON (67386-122-52) > 2 mL in 1 VIAL |
NDC Code | 67386-122-52 |
Proprietary Name | NeoProfen |
Package Description | 3 VIAL in 1 CARTON (67386-122-52) > 2 mL in 1 VIAL |
Product NDC | 67386-122 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ibuprofen lysine |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20060413 |
Marketing Category Name | NDA |
Labeler Name | Lundbeck Inc. |
Substance Name | IBUPROFEN LYSINE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |